You are here:
The medical advisory board comprises distinguished scientists and leaders of medical research and physics institutions. It provides insight, scientific direction, and expertise to Advanced Oncotherapy’s leadership team.
We are leaders in the next generation of proton systems which do not require a cyclotron or synchrotron. We develop cost effective treatments which are clinically superior to those currently available.
Our strategy is to provide wider and cost-effective access to radiation treatment through a ground-breaking proton therapy system with superior clinical benefits for cancer patients.
Our team is made up of highly skilled professionals who have a wide range of experience in their field.
Advanced Oncotherapy was created in 2012, leveraging the work and know-how of CERN experts in accelerator and detector technologies.
We have a strong foundation of core company values which underpin everything we do.
Our board brings entrepreneurial, commercial and financial leadership.
Advanced Oncotherapy is committed to the highest standards of corporate governance, business integrity and professionalism. The Directors recognise the importance of sound corporate governance.
Interviews highlighting the depth and range of experience with Advanced Oncotherapy.
Site by Purple Creative Studio -